COMPASS INC - CLASS A
COMPNYSE🏆 #1015 by market capEarnings Nov 5 · PostUS Equity
$9.17▼ $0.57 (−5.81%)
🌙 After hours$9.17▲ 0.02%Regular close · extended-hours price shownTrack COMP
Get earnings, price moves & breaking news on Telegram
24h▼ 5.8%
7d▼ 5.7%
14d▲ 4.7%
30d▲ 0.6%
ytd▼ 13.3%
1y▲ 15.6%
🏦Market Cap
$6.94B
Small Cap
📈Revenue Growth (YoY)
23.7%
Healthy
📊Gross Margin
12.7%
Thin
💵FCF Margin
1.2%
Thin
⚖️P/S Ratio
0.7x
Cheap
Otter Score
52
Fair
COMPASS INC - CLASS A
COMPAnalyst Ratings
Price
$9.17
Total
11
Raised
1
Lowered
1
Avg PT
$13.75
H / L
$18 / $10
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Zelman & Assoc | Upgraded | Neutral → Outperform | 2026-10-21 | — | — |
Needham | Reiterated | Buy | 2026-10-16 | $8.00 | −12.70% |
Wells Fargo | Reiterated | Equal Weight | 2026-10-12 | $10.00 | +9.10% |
Oppenheimer | Reiterated | Outperform | 2026-08-05 | $18.00 | +96.40% |
Barclays | Reiterated | Overweight | 2026-08-05 | $16.00 | +74.60% |
Goldman Sachs | Reiterated | Neutral | 2026-08-05 | $12.00 | +30.90% |
UBS | Reiterated | Buy | 2026-07-31 | $17.00 | +85.50% |
Morgan Stanley | Reiterated | Equal Weight | 2026-05-06 | $12.50 | +36.40% |
BTIG | Reiterated | Buy | 2026-01-08 | $12.00 | +30.90% |
Gordon Haskett | Downgraded | Hold → Underperform | 2024-02-21 | — | — |
Berenberg | Reiterated | Buy | 2022-01-11 | — | — |
Institution
Zelman & Assoc
Upgraded · Neutral → Outperform · 2026-10-21
—
—
Needham
Reiterated · Buy · 2026-10-16
$8.00
−12.70%
Wells Fargo
Reiterated · Equal Weight · 2026-10-12
$10.00
+9.10%
Oppenheimer
Reiterated · Outperform · 2026-08-05
$18.00
+96.40%
Barclays
Reiterated · Overweight · 2026-08-05
$16.00
+74.60%
Goldman Sachs
Reiterated · Neutral · 2026-08-05
$12.00
+30.90%
UBS
Reiterated · Buy · 2026-07-31
$17.00
+85.50%
Morgan Stanley
Reiterated · Equal Weight · 2026-05-06
$12.50
+36.40%
BTIG
Reiterated · Buy · 2026-01-08
$12.00
+30.90%
Gordon Haskett
Downgraded · Hold → Underperform · 2024-02-21
—
—
Berenberg
Reiterated · Buy · 2022-01-11
—
—
One row per institution · price target from the firm's latest published target